Poorya Hosseini

Partner

2021 - Current

- Early-stage investments in life sciences and healthcare startups [focus on Seed / Series A] - Leading an initiative for incubation of pioneering ventures with next-gen entrepreneurs - Stealth RNA Therapeutics Platform (Founding CEO) - Carbon Biosciences (Board Observer)

Senior Associate

2017 - 2021

During my tenure, I worked as part of a team of entrepreneurial scientists to conceive, create, resource, and develop the next generation of Flagship’s ventures and helped train the next generation of scientists and venture builders.

Founding Team

2019 - 2021

Flagship Labs 72, Inc. (FL72) is an early-stage biotechnology company that is developing a new category of immune therapeutics (Stealth). I led the origination and launch of the company in addition to leading Operations and R&D during my tenure at Flagship.

Founding Team

2018 - 2021

Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of machine learning, biological engineering, and medicine—pioneering Generative Biology™ to create breakthrough medicines.

Founding Team

2017 - 2021

The company's broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them.

Entrepreneurial Fellow

2017 - 2017

PHD Candidate

2012 - 2017

I developed advanced imaging and microscopy techniques for biomedical applications. On the application side, I focused on anemic disorders and sickle cell disease in particular.

Graduate Research Assistant

2008 - 2010